VIR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,697,678.88

Vir Biotechnology Insider Trading History Chart

Vir Biotechnology Share Price & Price History

^$7.34

▼ -0.03 (-0.41%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Vir Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/2/2024	Verneuil Vanina De	EVP	Sell	76	$8.22	$624.72	56,973
11/5/2024	Verneuil Vanina De	EVP	Sell	2,347	$9.47	$22,226.09	61,370
11/1/2024	Verneuil Vanina De	EVP	Sell	1,403	$7.20	$10,101.60	63,717
9/9/2024	Janet Napolitano	Director	Sell	12,190	$7.80	$95,082.00	11,616
6/11/2024	Saira Ramasastry	Director	Sell	4,000	$10.95	$43,800.00	14,619
4/3/2024	Backer Marianne De	CEO	Sell	72,995	$9.46	$690,532.70	678,457
4/1/2024	Ann M. Hanly	EVP	Sell	2,711	$10.05	$27,245.55	132,069
3/27/2024	Sung Lee	CFO	Sell	6,008	$9.89	$59,419.12	100,492
2/26/2024	George A. Scangos	Director	Sell	17,722	$11.65	$206,461.30	112,989
2/22/2024	Ann M. Hanly	EVP	Sell	12,296	$10.05	$123,574.80	134,780
2/22/2024	George A. Scangos	Director	Sell	10,028	$10.05	$100,781.40	130,711
2/20/2024	George A. Scangos	Director	Sell	16,872	$10.22	$172,431.84	140,739
2/16/2024	George A. Scangos	Director	Sell	10,878	$10.24	$111,390.72	157,611
2/16/2024	Phillip Pang	EVP	Sell	3,321	$10.24	$34,007.04	264,679
6/30/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	700	$25.11	$17,577.00	16,684,041
6/30/2023	Vicki L. Sato	Director	Sell	18,000	$24.66	$443,880.00	1,315,351
6/28/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	7,010	$25.10	$175,951.00	16,774,683
6/20/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	9,902	$25.18	$249,332.36	16,781,693
6/15/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	55,182	$25.85	$1,426,454.70	16,919,739
6/13/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	106,854	$27.09	$2,894,674.86	17,032,169
6/7/2023	Phillip Pang	Insider	Sell	5,000	$25.95	$129,750.00	188,000
6/5/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	5,197	$27.32	$141,982.04	17,139,023
6/2/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	34,365	$27.32	$938,851.80	17,144,220
6/1/2023	Saira Ramasastry	Director	Sell	3,500	$25.67	$89,845.00	10,619
6/1/2023	Steven J. Rice	Insider	Sell	2,500	$25.67	$64,175.00	106,840
5/24/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	104,384	$26.15	$2,729,641.60	17,178,585
5/22/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	91,896	$25.72	$2,363,565.12	17,453,036
5/19/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	91,651	$25.38	$2,326,102.38	17,544,932
5/5/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	136	$25.10	$3,413.60	17,636,583
5/3/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	83,674	$25.51	$2,134,523.74	17,751,051
5/1/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	3,075	$25.30	$77,797.50	17,834,725
4/24/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	66,038	$25.42	$1,678,685.96	17,838,761
4/21/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	305,393	$25.78	$7,873,031.54	17,904,799
4/19/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	76,114	$25.12	$1,911,983.68	18,216,782
4/17/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	10,524	$25.06	$263,731.44	18,299,849
4/14/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	9,565	$25.11	$240,177.15	18,310,373
3/30/2023	Ann M. Hanly	CTO	Sell	2,627	$22.77	$59,816.79	114,576
3/8/2023	Vicki L. Sato	Director	Sell	17,935	$22.59	$405,151.65	1,327,324
3/3/2023	Johanna Friedl-Naderer	COO	Sell	1,482	$22.82	$33,819.24	148,518
2/23/2023	Ann M. Hanly	CTO	Sell	2,302	$25.97	$59,782.94	117,203
2/23/2023	George A. Scangos	CEO	Sell	12,631	$25.97	$328,027.07	183,608
2/23/2023	Howard Horn	CFO	Sell	2,248	$25.97	$58,380.56	230,712
2/23/2023	Phillip Pang	Insider	Sell	2,878	$25.97	$74,741.66	198,320
2/21/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	74,477	$28.43	$2,117,381.11	18,319,938
2/21/2023	George A. Scangos	CEO	Sell	17,856	$28.30	$505,324.80	196,239
2/17/2023	George A. Scangos	CEO	Sell	9,894	$25.29	$250,219.26	214,095
2/17/2023	Howard Horn	CFO	Sell	2,424	$25.29	$61,302.96	232,960
2/17/2023	Steven J. Rice	Insider	Sell	1,981	$25.29	$50,099.49	37,209
2/15/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	38,964	$26.75	$1,042,287.00	18,394,415
2/13/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	79,050	$26.02	$2,056,881.00	18,472,286
2/10/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	97,221	$26.13	$2,540,384.73	18,551,336
2/8/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	81,914	$27.88	$2,283,762.32	18,785,607
2/8/2023	Vicki L. Sato	Director	Sell	17,915	$28.38	$508,427.70	1,345,259
2/6/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	45,249	$29.92	$1,353,850.08	18,931,029
2/3/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	68,786	$30.40	$2,091,094.40	18,976,278
2/1/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	61,834	$29.02	$1,794,422.68	19,131,865
1/30/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	78,930	$29.46	$2,325,277.80	19,267,582
1/24/2023	Phillip Pang	Insider	Sell	30,000	$30.00	$900,000.00	144,000
1/23/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	36,512	$28.34	$1,034,750.08	19,346,512
1/19/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	69,839	$26.56	$1,854,923.84	19,527,382
1/17/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	88,372	$26.24	$2,318,881.28	19,699,688
1/13/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	94,199	$26.54	$2,500,041.46	19,788,060
1/11/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	79,065	$26.24	$2,074,665.60	19,999,738
1/9/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	34,801	$25.85	$899,605.85	20,149,378
1/9/2023	Vicki L. Sato	Director	Sell	17,915	$25.83	$462,744.45	1,363,174
1/6/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	66,179	$26.13	$1,729,257.27	20,184,179
1/5/2023	Charles Elliott Sigal	Director	Buy	2,500	$24.96	$62,400.00	7,500
1/3/2023	Charles Elliott Sigal	Director	Buy	2,500	$25.60	$64,000.00	2,500
1/3/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	8,177	$25.58	$209,167.66	20,251,358
12/27/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	6,850	$25.59	$175,291.50	20,303,704
12/22/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	95,144	$26.07	$2,480,404.08	20,390,635
12/20/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	104,026	$25.53	$2,655,783.78	20,597,509
12/5/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	8,831	$27.25	$240,644.75	20,701,535
12/2/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	88,462	$27.47	$2,430,051.14	20,710,366
11/30/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	165,953	$27.85	$4,621,791.05	20,845,204
11/28/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	37,989	$27.46	$1,043,177.94	21,082,283
11/25/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	17,264	$27.21	$469,753.44	21,120,272
11/23/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	39,729	$27.30	$1,084,601.70	21,137,536
11/21/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	720	$27.13	$19,533.60	21,242,478
11/18/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	25,259	$27.21	$687,297.39	21,243,198
11/14/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	50,173	$27.41	$1,375,241.93	21,566,288
11/8/2022	Vicki L. Sato	Director	Sell	17,915	$27.38	$490,512.70	1,399,004
11/7/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	132,978	$27.22	$3,619,661.16	21,953,302
10/10/2022	Vicki L. Sato	Director	Sell	17,915	$20.67	$370,303.05	1,416,919
9/8/2022	Vicki L. Sato	Director	Sell	17,915	$21.90	$392,338.50	1,434,834
8/15/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	122,564	$27.99	$3,430,566.36	22,094,080
7/20/2022	Phillip Pang	Insider	Sell	5,000	$30.00	$150,000.00	144,000
7/11/2022	Saira Ramasastry	Director	Sell	5,000	$30.00	$150,000.00	8,092
7/8/2022	Vicki L. Sato	Director	Sell	17,915	$29.06	$520,609.90	1,470,664
6/21/2022	Phillip Pang	Insider	Sell	4,991	$24.89	$124,225.99	144,000
6/8/2022	Vicki L. Sato	Director	Sell	17,915	$25.84	$462,923.60	1,488,579
5/24/2022	Saira Ramasastry	Director	Sell	1,687	$23.82	$40,184.34	8,092
5/9/2022	Vicki L. Sato	Director	Sell	14,541	$20.62	$299,835.42	1,503,463
4/28/2022	Vicki L. Sato	Director	Sell	17,915	$20.90	$374,423.50	1,518,004
3/30/2022	Ann M. Hanly	CTO	Sell	2,627	$26.24	$68,932.48
2/22/2022	Herbert Virgin	EVP	Sell	1,375	$30.00	$41,250.00
2/17/2022	George A. Scangos	CEO	Sell	10,024	$31.93	$320,066.32
2/17/2022	Herbert Virgin	EVP	Sell	2,293	$31.93	$73,215.49
2/17/2022	Howard Horn	CFO	Sell	2,393	$31.93	$76,408.49
2/16/2022	Phillip Pang	Insider	Sell	5,000	$31.54	$157,700.00
2/8/2022	Herbert Virgin	EVP	Sell	1,375	$33.94	$46,667.50
2/2/2022	Phillip Pang	Insider	Sell	5,000	$34.52	$172,600.00
1/25/2022	Herbert Virgin	EVP	Sell	1,375	$32.46	$44,632.50
1/19/2022	Phillip Pang	Insider	Sell	5,000	$35.06	$175,300.00
1/18/2022	Vicki L. Sato	Director	Sell	15,173	$37.39	$567,318.47
1/11/2022	Herbert Virgin	EVP	Sell	1,375	$35.10	$48,262.50
1/5/2022	Phillip Pang	Insider	Sell	5,000	$37.19	$185,950.00
12/28/2021	Herbert Virgin	EVP	Sell	1,375	$39.95	$54,931.25
12/20/2021	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	400,022	$52.73	$21,093,160.06

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Vir Biotechnology (NASDAQ:VIR)

65.32% of Vir Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vir Biotechnology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	431,411	$3.23M	0.0%	-0.7%	0.313%
11/27/2024	Franklin Resources Inc.	97,948	$0.75M	0.0%	-2.2%	0.071%
11/16/2024	Geode Capital Management LLC	2,188,774	$16.40M	0.0%	+0.2%	1.589%
11/15/2024	Barclays PLC	550,186	$4.12M	0.0%	+1.3%	0.399%
11/15/2024	Y Intercept Hong Kong Ltd	22,455	$0.17M	0.0%	-78.4%	0.016%
11/15/2024	Jane Street Group LLC	130,347	$0.98M	0.0%	-1.0%	0.095%
11/15/2024	Sphera Funds Management LTD.	93,329	$0.70M	0.1%	-42.4%	0.068%
11/15/2024	State Street Corp	5,625,533	$42.14M	0.0%	+10.4%	4.085%
11/15/2024	Quarry LP	17,000	$0.13M	0.0%	+901.8%	0.012%
11/15/2024	Point72 Asset Management L.P.	5,215	$39K	0.0%	-70.4%	0.004%
11/15/2024	Jacobs Levy Equity Management Inc.	350,265	$2.62M	0.0%	+10.6%	0.254%
11/15/2024	Erste Asset Management GmbH	28,800	$0.22M	0.0%	N/A	0.021%
11/14/2024	PDT Partners LLC	220,821	$1.65M	0.1%	+34.4%	0.160%
11/14/2024	Verition Fund Management LLC	52,794	$0.40M	0.0%	N/A	0.038%
11/14/2024	Captrust Financial Advisors	15,820	$0.12M	0.0%	N/A	0.011%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	140,371	$1.05M	0.0%	-17.7%	0.102%
11/14/2024	Public Sector Pension Investment Board	194,208	$1.46M	0.0%	+1.4%	0.141%
11/13/2024	Quantbot Technologies LP	18,452	$0.14M	0.0%	N/A	0.013%
11/13/2024	Dynamic Technology Lab Private Ltd	31,900	$0.24M	0.0%	+77.2%	0.023%
11/12/2024	Algert Global LLC	213,465	$1.60M	0.0%	+27.9%	0.155%
11/12/2024	Valence8 US LP	33,650	$0.25M	0.1%	N/A	0.024%
11/12/2024	Charles Schwab Investment Management Inc.	1,134,276	$8.50M	0.0%	+13.6%	0.824%
11/9/2024	Intech Investment Management LLC	25,522	$0.19M	0.0%	N/A	0.019%
11/7/2024	Quest Partners LLC	34,455	$0.26M	0.0%	+171.4%	0.025%
11/6/2024	Empowered Funds LLC	329,781	$2.47M	0.0%	-33.2%	0.241%
11/6/2024	Cornercap Investment Counsel Inc.	10,587	$79K	0.0%	-53.0%	0.008%
11/5/2024	Victory Capital Management Inc.	81,269	$0.61M	0.0%	+23.9%	0.059%
11/5/2024	Baillie Gifford & Co.	2,383,029	$17.85M	0.0%	-39.2%	1.744%
10/31/2024	Principal Financial Group Inc.	431,411	$3.23M	0.0%	-0.7%	0.316%
10/25/2024	China Universal Asset Management Co. Ltd.	26,280	$0.20M	0.0%	+64.4%	0.019%
10/23/2024	Hennion & Walsh Asset Management Inc.	35,132	$0.26M	0.0%	-9.5%	0.026%
10/21/2024	Everence Capital Management Inc.	12,780	$96K	0.0%	-40.4%	0.009%
10/18/2024	Blue Trust Inc.	3,989	$30K	0.0%	+143.5%	0.003%
10/16/2024	nVerses Capital LLC	7,500	$56K	0.0%	N/A	0.005%
10/16/2024	Vontobel Holding Ltd.	57,446	$0.43M	0.0%	+27.8%	0.042%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	18,959	$0.17M	0.0%	+491.7%	0.014%
8/19/2024	Point72 Asset Management L.P.	17,600	$0.16M	0.0%	-45.8%	0.013%
8/16/2024	Algert Global LLC	166,835	$1.49M	0.0%	N/A	0.123%
8/15/2024	Susquehanna Fundamental Investments LLC	15,200	$0.14M	0.0%	N/A	0.011%
8/15/2024	The Manufacturers Life Insurance Company	48,987	$0.44M	0.0%	+7.9%	0.036%
8/15/2024	Millennium Management LLC	1,248,131	$11.11M	0.0%	+94.6%	0.917%
8/15/2024	AQR Capital Management LLC	15,037	$0.13M	0.0%	-42.3%	0.011%
8/15/2024	Affinity Asset Advisors LLC	200,000	$1.78M	0.2%	N/A	0.147%
8/15/2024	Caxton Associates LP	59,625	$0.53M	0.0%	N/A	0.044%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	18,959	$0.17M	0.0%	+491.7%	0.014%
8/15/2024	Point72 Hong Kong Ltd	19,572	$0.17M	0.0%	+180.6%	0.014%
8/14/2024	Cubist Systematic Strategies LLC	188,624	$1.68M	0.0%	+6,402.0%	0.139%
8/14/2024	Point72 DIFC Ltd	26,917	$0.24M	0.0%	+199.9%	0.020%
8/14/2024	Magnetar Financial LLC	10,668	$95K	0.0%	N/A	0.008%
8/14/2024	Public Sector Pension Investment Board	191,608	$1.71M	0.0%	+7.2%	0.141%
8/14/2024	ProShare Advisors LLC	21,355	$0.19M	0.0%	-19.1%	0.016%
8/14/2024	Profund Advisors LLC	30,128	$0.27M	0.0%	-57.6%	0.022%
8/13/2024	Thrivent Financial for Lutherans	72,287	$0.64M	0.0%	-3.2%	0.053%
8/12/2024	XTX Topco Ltd	48,399	$0.43M	0.0%	N/A	0.035%
8/12/2024	Hsbc Holdings PLC	46,222	$0.41M	0.0%	+148.3%	0.034%
8/12/2024	Amalgamated Bank	25,740	$0.23M	0.0%	-7.3%	0.019%
8/9/2024	Renaissance Technologies LLC	1,329,700	$11.83M	0.0%	-1.9%	0.977%
8/9/2024	Dimensional Fund Advisors LP	637,486	$5.67M	0.0%	+10.1%	0.469%
8/9/2024	Rathbones Group PLC	28,611	$0.26M	0.0%	-10.8%	0.021%
8/9/2024	WINTON GROUP Ltd	99,711	$0.89M	0.1%	+23.0%	0.073%
8/8/2024	Federated Hermes Inc.	300,148	$2.67M	0.0%	+19,327.1%	0.220%
8/8/2024	American Century Companies Inc.	168,235	$1.50M	0.0%	+12.7%	0.124%
8/7/2024	Headlands Technologies LLC	32,289	$0.29M	0.0%	+175.2%	0.024%
8/7/2024	Texas Permanent School Fund Corp	64,439	$0.57M	0.0%	-14.1%	0.047%
8/6/2024	Quest Partners LLC	12,695	$0.11M	0.0%	+142.1%	0.009%
8/6/2024	Ballentine Partners LLC	12,519	$0.11M	0.0%	-8.6%	0.009%
8/6/2024	Los Angeles Capital Management LLC	13,331	$0.12M	0.0%	N/A	0.010%
8/5/2024	Victory Capital Management Inc.	65,573	$0.58M	0.0%	+41.5%	0.048%
8/1/2024	Rhumbline Advisers	238,504	$2.12M	0.0%	+4.3%	0.175%
7/31/2024	Commonwealth Equity Services LLC	63,235	$0.56M	0.0%	-4.6%	0.046%
7/29/2024	Principal Financial Group Inc.	434,626	$3.87M	0.0%	-5.9%	0.319%
7/29/2024	Innealta Capital LLC	3,541	$32K	0.0%	N/A	0.003%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	24,647	$0.22M	0.0%	+15.0%	0.018%
7/26/2024	Bank of New York Mellon Corp	813,288	$7.24M	0.0%	+0.8%	0.598%
7/25/2024	Baillie Gifford & Co.	3,921,242	$34.90M	0.0%	-0.7%	2.882%
7/24/2024	Louisiana State Employees Retirement System	43,800	$0.39M	0.0%	+2.8%	0.032%
5/17/2024	Comerica Bank	32,492	$0.33M	0.0%	-8.4%	0.024%
5/17/2024	Tidal Investments LLC	34,750	$0.35M	0.0%	N/A	0.026%
5/16/2024	California State Teachers Retirement System	93,112	$0.94M	0.0%	-4.5%	0.068%
5/16/2024	Jacobs Levy Equity Management Inc.	310,091	$3.14M	0.0%	+5.7%	0.228%
5/16/2024	Bayesian Capital Management LP	25,600	$0.26M	0.0%	N/A	0.019%
5/15/2024	Price T Rowe Associates Inc. MD	53,379	$0.54M	0.0%	-38.4%	0.039%
5/10/2024	Vanguard Group Inc.	12,375,355	$125.36M	0.0%	+0.6%	9.201%
5/9/2024	Mitsubishi UFJ Asset Management Co. Ltd.	23,979	$0.24M	0.0%	-4.4%	0.018%
5/8/2024	ProShare Advisors LLC	26,392	$0.27M	0.0%	+8.4%	0.020%
5/8/2024	Russell Investments Group Ltd.	25,971	$0.26M	0.0%	+116.6%	0.019%
5/8/2024	Headlands Technologies LLC	11,733	$0.12M	0.0%	N/A	0.009%
5/7/2024	Empowered Funds LLC	458,044	$4.64M	0.1%	+8.2%	0.341%
5/6/2024	Duality Advisers LP	101,479	$1.03M	0.1%	+6.7%	0.075%
5/6/2024	Texas Permanent School Fund Corp	74,977	$0.76M	0.0%	+1.4%	0.056%
5/2/2024	Nordea Investment Management AB	235,664	$2.41M	0.0%	+58.7%	0.175%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	49,525	$0.50M	0.0%	-76.7%	0.037%
5/1/2024	Baillie Gifford & Co.	3,947,065	$39.98M	0.0%	-0.5%	2.935%
4/29/2024	Principal Financial Group Inc.	462,030	$4.68M	0.0%	-9.0%	0.344%
4/29/2024	China Universal Asset Management Co. Ltd.	25,974	$0.26M	0.0%	+66.9%	0.019%
4/26/2024	Yousif Capital Management LLC	31,748	$0.32M	0.0%	-10.2%	0.024%
4/17/2024	Hennion & Walsh Asset Management Inc.	39,150	$0.40M	0.0%	+14.4%	0.029%
4/11/2024	Ballentine Partners LLC	13,704	$0.14M	0.0%	+9.2%	0.010%
4/5/2024	GAMMA Investing LLC	2,708	$27K	0.0%	+249.9%	0.002%
3/22/2024	PNC Financial Services Group Inc.	11,186	$0.11M	0.0%	+20.1%	0.008%

Data available starting January 2016

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Today's Range

Now: $7.34

$7.23

$7.56

50 Day Range

MA: $8.02

$6.74

$10.17

52 Week Range

Now: $7.34

$6.56

$13.09

Volume

3,745,310 shs

Average Volume

1,084,083 shs

Market Capitalization

$1.01 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of Vir Biotechnology?: Vir Biotechnology's top insider investors include:
Endurance (Cayman) Ltd Svf (Major Shareholder)
Vicki L Sato (Director)
Backer Marianne De (CEO)
Phillip Pang (EVP)
Howard Horn (CFO)
George A Scangos (CEO)
Phillip Pang (Insider)
George A Scangos (Director)
Johanna Friedl-Naderer (COO)
Ann M Hanly (EVP)
Ann M Hanly (CTO)
Steven J Rice (Insider)
Sung Lee (CFO)
Verneuil Vanina De (EVP)
Saira Ramasastry (Director)
Janet Napolitano (Director)
Charles Elliott Sigal (Director)
Learn More about top insider investors at Vir Biotechnology.
Who are the major institutional investors of Vir Biotechnology?: Vir Biotechnology's top institutional investors include:
State Street Corp — 4.08%
Baillie Gifford & Co. — 1.74%
Geode Capital Management LLC — 1.59%
Charles Schwab Investment Management Inc. — 0.82%
Barclays PLC — 0.40%
Principal Financial Group Inc. — 0.32%
Learn More about top institutional investors of Vir Biotechnology stock.
Which institutional investors are selling Vir Biotechnology stock?: In the previous quarter, VIR stock was sold by these institutional investors:
Baillie Gifford & Co.
Empowered Funds LLC
Y Intercept Hong Kong Ltd
Sphera Funds Management LTD.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Point72 Asset Management L.P.
Cornercap Investment Counsel Inc.
Everence Capital Management Inc.
In the last year, company insiders that have sold Vir Biotechnology company stock include:
Endurance (Cayman) Ltd Svf (Major Shareholder)
Vicki L Sato (Director)
Backer Marianne De (CEO)
Phillip Pang (EVP)
Howard Horn (CFO)
George A Scangos (CEO)
Phillip Pang (Insider)
George A Scangos (Director)
Learn More investors selling Vir Biotechnology stock.
Which institutional investors are buying Vir Biotechnology stock?: During the previous quarter, VIR stock was bought by institutional investors including:
State Street Corp
Charles Schwab Investment Management Inc.
PDT Partners LLC
Verition Fund Management LLC
Algert Global LLC
Valence8 US LP
Jacobs Levy Equity Management Inc.
Erste Asset Management GmbH